TRINITY BIOTECH PLCTRIBEarnings & Financial Report
Nasdaq
Trinity Biotech PLC develops, manufactures and markets diagnostic test kits and systems for clinical laboratories and point-of-care settings. Its product portfolio covers diabetes management, infectious diseases, cardiac health, autoimmune disorders and coagulation, with core markets across North America, Europe and emerging economies.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| MiCo IVD Holdings, LLC | 29.99% | 46.3M | — | 2024-01-02 |
| Perceptive Advisors LLC | 22.60% | 56.0M | ▼ -4.20pp | 2024-11-14 |
| MiCo Co., Ltd. | 0.00% | 896.4M | — | 2024-01-02 |